NGM

Ngm Biopharmaceuticals Inc

No insider bought or sold Ngm Biopharmaceuticals Inc in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow NGM

NGM over the last year

Prices for NGM aren't in yet.

NGM after insider buys

3 months after each buy, from the first price a copier could get.

−24.1%Average

−26.5 ptsVs S&P 500

0 of 5Higher

5 buys since 2019 with 3 months of prices.

Every filing

114 insider filings since 2019, newest first

NGMBuy

David Goeddel V · Director and 10% owner

$921K+1.0%Feb 1

NGMBuy

Column Group L P · Director and 10% owner

$921K+1.0%Feb 1

NGMBuy

David Goeddel V · Director and 10% owner

$49KJan 25

NGMBuy

Column Group L P · Director and 10% owner

$49KJan 25

NGMBuy

David Goeddel V · Director and 10% owner

$191KJan 23

NGMBuy

Column Group L P · Director and 10% owner

$191KJan 23

NGMSell

Jin-Long Chen · Chief Scientific Officer

$438K−9.0%Jan 18

NGMBuy

David Goeddel V · Director and 10% owner

$27KJan 17

NGMBuy

Column Group L P · Director and 10% owner

$27KJan 17

NGMBuy

David Goeddel V · Director and 10% owner

$1.5M+1.0%Jan 12

NGMBuy

Column Group L P · Director and 10% owner

$1.5M+1.0%Jan 12

NGMBuy

David Goeddel V · Director and 10% owner

$684K+1.0%Nov 7

NGMBuy

Column Group L P · Director and 10% owner

$684K+1.0%Nov 7

NGMBuy

David Goeddel V · Director and 10% owner

$446KJun 6

NGMBuy

Column Group L P · Director and 10% owner

$446KJun 6

NGMBuy

David Goeddel V · Director and 10% owner

$2.1M+1.0%Jun 2

NGMBuy

Column Group L P · Director and 10% owner

$2.1M+1.0%Jun 2

NGMBuy

David Goeddel V · Director and 10% owner

$428K+1.0%May 17

NGMBuy

Column Group L P · Director and 10% owner

$428K+1.0%May 17

NGMBuy

David Goeddel V · Director and 10% owner

$1.9M+1.0%May 13

NGMBuy

Column Group L P · Director and 10% owner

$1.9M+1.0%May 13

NGMBuy

David Goeddel V · Director and 10% owner

$1.3M+1.0%May 11

NGMBuy

Column Group L P · Director and 10% owner

$1.3M+1.0%May 11

NGMSell

David J Woodhouse · CEO

$300K−16.0%Nov 19

NGMSell

Jin-Long Chen · Chief Scientific Officer

$592K−3.0%Nov 16

NGMSell

Jin-Long Chen · Chief Scientific Officer

$608K−3.0%Oct 13

NGMSell

Hsiao D Lieu · SVP and Chief Medical Officer

$44K−100.0%Oct 7

NGMSell

Jin-Long Chen · Chief Scientific Officer

$775K−3.0%Sep 14

NGMSell

Hsiao D Lieu · SVP and Chief Medical Officer

$240K−100.0%Aug 13

NGMSell

Jin-Long Chen · Chief Scientific Officer

$714K−3.0%Aug 11

NGMSell

Jin-Long Chen · Chief Scientific Officer

$691K−3.0%May 4

NGMSell

Jin-Long Chen · Chief Scientific Officer

$616K−3.0%Apr 13

NGMSell

Jin-Long Chen · Chief Scientific Officer

$667K−3.0%Mar 2

NGMSell

Jin-Long Chen · Chief Scientific Officer

$719K−2.0%Feb 17

NGMSell

Jin-Long Chen · Chief Scientific Officer

$732K−2.0%Jan 6

NGMSell

Jin-Long Chen · Chief Scientific Officer

$700K−3.0%Dec 16

NGMSell

Jin-Long Chen · Chief Scientific Officer

$443K−3.0%Nov 4

NGMSell

Jin-Long Chen · Chief Scientific Officer

$426K−3.0%Oct 13

NGMSell

Jin-Long Chen · Chief Scientific Officer

$446K−3.0%Sep 3

NGMBuy

Column Group L P · Director and 10% owner

$1.1MSep 3

NGMBuy

Column Group L P · Director and 10% owner

$1.1MAug 31

NGMBuy

Column Group L P · Director and 10% owner

$331KAug 25

NGMBuy

Column Group L P · Director and 10% owner

$1.1MAug 17

NGMSell

Jin-Long Chen · Chief Scientific Officer

$476K−2.0%Aug 11

NGMSell

Jin-Long Chen · Chief Scientific Officer

$473K−2.0%Jul 2

NGMSell

Jin-Long Chen · Chief Scientific Officer

$541K−2.0%Jun 17

NGMSell

Hsiao D Lieu · SVP and Chief Medical Officer

$34K−90.0%May 18

NGMBuy

Peter Svennilson · Director and 10% owner

$3.6M+2.0%Mar 25

NGMBuy

David Goeddel V · Director and 10% owner

$3.6M+2.0%Mar 25

NGMBuy

Column Group L P · 10% owner

$3.6M+2.0%Mar 25

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.